Prognostic evaluation of human papillomavirus and p16 in esophageal squamous cell carcinoma

Chin Med J (Engl). 2020 Mar 20;133(6):751-752. doi: 10.1097/CM9.0000000000000662.

Authors

Cheng-Juan Zhang^{1

2}, Jun-Xia Zhang³, Zhi-Zhong Wang¹, Peng Li⁴, Jin-Wen Shang¹, Yong-Jun Guo¹

Affiliations

¹ Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China.
² Provincial Cooperative Innovation Center for Cancer Chemoprevention, Zhengzhou University, Zhengzhou, Henan 450000, China.
³ Academy of Chinese Medicine Sciences, Henan University of Chinese Medicine, Zhengzhou, Henan 450000, China.
⁴ Department of Infectious Control, Henan Provincial People's Hospital, Zhengzhou, Henan 450000, China.

No abstract available

MeSH terms

Alphapapillomavirus / pathogenicity*
Esophageal Neoplasms / genetics
Esophageal Neoplasms / metabolism*
Esophageal Neoplasms / mortality
Esophageal Neoplasms / virology*
Esophageal Squamous Cell Carcinoma / genetics
Esophageal Squamous Cell Carcinoma / metabolism*
Esophageal Squamous Cell Carcinoma / mortality
Esophageal Squamous Cell Carcinoma / virology*
Humans
Kaplan-Meier Estimate
Oropharyngeal Neoplasms / genetics
Oropharyngeal Neoplasms / metabolism*
Oropharyngeal Neoplasms / mortality
Oropharyngeal Neoplasms / virology*
Prognosis
Survival Rate
Tumor Suppressor Protein p53 / genetics
Tumor Suppressor Protein p53 / metabolism
Viral Core Proteins / genetics
Viral Core Proteins / metabolism*

Substances

Tumor Suppressor Protein p53
Viral Core Proteins